{"protocolSection": {"identificationModule": {"nctId": "NCT02656329", "orgStudyIdInfo": {"id": "GE-122-020"}, "secondaryIdInfos": [{"id": "2015-001464-19", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "GE Healthcare", "class": "INDUSTRY"}, "briefTitle": "International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device", "officialTitle": "AdreView\u2122 Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%\u2264LVEF\u226435%", "acronym": "ADMIRE-ICD"}, "statusModule": {"statusVerifiedDate": "2019-04", "overallStatus": "TERMINATED", "whyStopped": "Sponsor discretion (low recruitment rate)", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2015-12-30", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-05-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-05-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-01-07", "studyFirstSubmitQcDate": "2016-01-12", "studyFirstPostDateStruct": {"date": "2016-01-14", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-04-26", "resultsFirstSubmitQcDate": "2019-04-26", "resultsFirstPostDateStruct": {"date": "2019-05-22", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-04-26", "lastUpdatePostDateStruct": {"date": "2019-05-22", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "GE Healthcare", "class": "INDUSTRY"}, "collaborators": [{"name": "Advanced Clinical, LLC", "class": "UNKNOWN"}, {"name": "TFS", "class": "UNKNOWN"}, {"name": "H2O Clinical LLC", "class": "INDUSTRY"}, {"name": "AG Mednet Inc.", "class": "UNKNOWN"}, {"name": "ICON CEAC", "class": "UNKNOWN"}, {"name": "ICON Clinical", "class": "UNKNOWN"}, {"name": "ABX CRO", "class": "OTHER"}, {"name": "TransPerfect", "class": "UNKNOWN"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "This is an event-driven Phase IIIb, multicentre, randomised, clinical study to demonstrate the efficacy of AdreView\u2122 imaging for appropriately guiding the decision of implantable cardioverter defibrillator (ICD) implantation, in New York Health Association (NYHA) class II and III heart failure participants with 25%\\<=left ventricular ejection fraction (LVEF)\\<=35%, and in particular, for identifying participants who are at low risk for sudden cardiac death and who would not benefit, or may suffer harm, from implantation of an ICD device."}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["Heart Failure (HF)", "Single photon emission computer tomography scan (SPECT)", "Implantable cardioverter defibrillator (ICD)", "Left Ventricular ejection fraction (LVEF)", "New York Health Association (NYHA)", "Metaiodobenzylguanidine (mIBG)", "123I-iobenguane", "Heart-to-mediastinal ratio (H/M)", "ADMIRE-ICD (AdreView Myocardial Imaging for Risk Evaluation - Implantable Cardioverter Defibrillator", "All-cause mortality", "Cardiac mortality"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 395, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "AdreView\u2122", "type": "EXPERIMENTAL", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 Heart-to-Mediastinal ratio (H/M) \\<1.6 underwent Implantable Cardioverter Defibrillator (ICD) device implantation and H/M \\>= 1.6 continued to receive Guideline-Directed Optimal Medical Therapy (GDMT) according to clinical standard practice.", "interventionNames": ["Drug: Iobenguane I -123 Injection", "Device: Implantable Cardioverter Defibrillator", "Drug: Thyroid blocking"]}, {"label": "Standard of Care", "type": "EXPERIMENTAL", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted Heart Failure (HF) guidelines.", "interventionNames": ["Drug: Iobenguane I -123 Injection", "Device: Implantable Cardioverter Defibrillator"]}], "interventions": [{"type": "DRUG", "name": "Iobenguane I -123 Injection", "description": "Iobenguane I-123 Injection, AdreView. All participants scheduled for an Iobenguane I-123 Injection, AdreView scan.", "armGroupLabels": ["AdreView\u2122"], "otherNames": ["AdreView", "Iobenguane I-123 Injection"]}, {"type": "DEVICE", "name": "Implantable Cardioverter Defibrillator", "description": "In the Iobenguane I-123 Injection group, participants with H/M ratio less or equal to 1.6 underwent ICD device implantation, while those with H/M ratio greater than or equal to 1.6 did not undergo ICD implantation.", "armGroupLabels": ["AdreView\u2122"]}, {"type": "DRUG", "name": "Thyroid blocking", "description": "Participants received a thyroid blocking agent before the Iobenguane I-123 Injection, AdreView, scan unless medically not indicated, according to local practice.", "armGroupLabels": ["AdreView\u2122"], "otherNames": ["Potassium Iodide", "Potassium Perchlorate", "Lugol's Solution"]}, {"type": "DRUG", "name": "Iobenguane I -123 Injection", "description": "Iobenguane I-123 Injection, AdreView. All participants scheduled for an Iobenguane I-123 Injection, AdreView scan.", "armGroupLabels": ["Standard of Care"], "otherNames": ["AdreView", "Iobenguane I-123 Injection"]}, {"type": "DEVICE", "name": "Implantable Cardioverter Defibrillator", "description": "All participants allocated to the SoC (control) group underwent ICD implantation.", "armGroupLabels": ["Standard of Care"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "All-cause Mortality", "description": "All-cause mortality included all reported deaths of participants during the study due to any cause. Percentage of participants who died due to any cause were reported.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}], "secondaryOutcomes": [{"measure": "Percentage of Participants With Events of Complications of Device: H/M >=1.6 in Full Analysis Set", "description": "Composite of the percentage of participants with events of hospitalization or death related to major complications of device implantation (i.e., need for thoracotomy, pericardiocentesis, or vascular surgery), complications of long-term device therapy (i.e., infection not leading to hospitalization, lead and/or generator removal/replacement, inappropriate shocks, explanation), and combined as 'complications of device' for participants with H/M \\>=1.6. Participants who were alive at time of database lock (DBL) were censored at the last known-alive date.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}, {"measure": "Percentage of Participants With Cardiac Death", "description": "Cardiac death composed of sudden cardiac death, death due to cardiac arrhythmia, death due to heart failure, and death due to other cardiovascular causes.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}, {"measure": "Percentage of Participants With Hospitalization for Cardiovascular Cause", "description": "Percentage of participants who were hospitalized for cardiovascular cause were reported.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}, {"measure": "Percentage of Participants With All-Cause Hospitalization", "description": "Percentage of participants with all-cause hospitalization were reported.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}, {"measure": "Percentage of Participants With Events (Composite of the Occurrence of Resuscitated Life-Threatening Ventricular Tachycardia, Unstable Ventricular Tachyarrhythmias, Sudden Cardiac Death [SCD] and Resuscitated Cardiac Arrest)", "description": "Percentage of participants with composite events i.e occurrence of resuscitated life-threatening ventricular tachycardia, unstable ventricular tachy-arrhythmias, SCD and resuscitated cardiac arrest were reported. Participants who were alive at time of database lock (DBL) were censored at the last known-alive date.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}, {"measure": "Percentage of Participants With Syncope", "description": "Percentage of participants with Syncope were reported. Participants who were alive at time of DBL were censored at the last known-alive date by date of DBL.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}, {"measure": "Percentage of Participants With Implantable Cardioverter Defibrillator (ICD) Implantation", "description": "Percentage of participants with ICD implantation were reported.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}, {"measure": "Percentage of Participants With Events of Complications of Device", "description": "Composite of the percentage of participants with events of hospitalization or death related to major complications of device implantation (i.e., need for thoracotomy, pericardiocentesis, or vascular surgery), complications of long-term device therapy (i.e., infection not leading to hospitalization, lead and/or generator removal/replacement, inappropriate shocks, explanation), and combined as 'complications of device'.", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Participants \\>=18 years of age at the time dated informed consent was obtained.\n* Female participants must be pre-menarchal, surgically sterile (had a documented bilateral oophorectomy and/or documented hysterectomy), postmenopausal (cessation of menses for more than 1 year), non-lactating, or, if of childbearing potential, a serum or urine pregnancy test with the results known prior to AdreView (Iobenguane I-123 Injection) administration) was negative.\n* Participants willing and able to comply with all study procedures and a signed and dated informed consent was obtained before any study-procedure was carried out.\n* Heart failure NYHA class II or III for symptoms, participants with ischemic or non-ischemic heart disease, eligible for ICD implantation as per each site's standard of practice.\n* Non-ischemic dilated cardiomyopathy or ischemic heart disease of at least 3 months duration receiving guideline-directed optimal medical therapy.\n* 25%\u2264LVEF\u226435%, performed within 3 months before or at time of enrollment, as measured by radionuclide ventriculography, or electrocardiogram \\[ECG\\]-gated SPECT myocardial perfusion imaging \\[MPI\\], or magnetic resonance imaging \\[MR\\], computed tomography \\[CT\\], or 3D or 2D echocardiography \\[Simpson's or multidisc method only, M-mode echocardiography was not accepted\\].\n\nIn case LVEF measurement was performed within 3 months before enrollment, measurement should be performed at least 40 days after a hospitalization for HF or acute coronary syndrome (including myocardial infarction), and to be valid, method of measurement should be in accordance with the protocol and the imaging exam should be made available to the Sponsor in digital format. In case several valid LVEF measurements are available, the closest to enrollment will be used for inclusion determination.\n\n* Clinically stable heart failure in the medical judgment of the investigator (i.e. no significant changes in medication, no worsening of symptoms, no unscheduled visits to the doctor's office) for the past 30 days and no hospitalization for heart failure or acute coronary syndrome (including myocardial infarction) in the past 40 days.\n* Reasonable expectation of meaningful survival for at least 1 year.\n\nExclusion Criteria:\n\n* Participants with existing ICD or participant having an indication of ICD implantation for secondary prevention of sudden cardiac death.\n* Hospitalization for HF or for acute coronary syndrome in the previous 40 days.\n* Participants where a cardiac resynchronisation therapy (CRT) was planned or indicated.\n* Other indication for placement of device (sustained ventricular tachycardia, resuscitated sudden death, need for atrioventricular pacing).\n* NYHA class I or class IV symptoms at the time of study entry.\n* Participants with chronic renal insufficiency defined as serum creatinine \u2265 3 mg/dl (or \u2265 265.2 \u00b5mol/L).\n* American College of College-American Heart Association (ACC-AHA) class III or class IV (unstable) angina.\n* Known or suspected hypersensitivity/allergy to Iobenguane or to any of the excipients an Adreview (Iobenguane I-131 injection).\n* Participant who was pregnant or plans to become pregnant within 2 weeks after AdreView (Iobenguane I-123 Injection) administration.\n* Participant who had used any medication in the 2 weeks before AdreView (Iobenguane I-123 Injection) that could interfere with the test: e.g. but not limited to amitriptyline or derivatives, imipramine or derivatives, other antidepressants or drugs known or suspected to inhibit the norepinephrine transporter, antihypertensives that deplete norepinephrine stores or inhibit reuptake, sympathomimetic amines or cocaine.\n* Participants that had a medical condition that could interfere with the AdreView test (e.g. but not limited to left ventricular assist device (LVAD), or prior heart transplant).\n* Participants who participated in a clinical study involving a drug or device within 30 days prior to study entry and participants participating in any other clinical study.\n* Participants having serious non-cardiac medical condition associated with significant elevation of plasma catecholamines, including pheochromocytoma.\n* Participants with a clinical diagnosis of (or being treated for) Parkinson's disease or Multiple System Atrophy.\n* The participant had participated in a research study using ionizing radiation in the previous 12 months.\n* Participants previously randomized in this study.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Vascular Biology and Hypertension Program, University of Alabama at Birmingham", "city": "Birmingham", "state": "Alabama", "zip": "35294", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Comprehensive Cardiovascular Medical Group", "city": "Bakersfield", "state": "California", "zip": "93309", "country": "United States", "geoPoint": {"lat": 35.37329, "lon": -119.01871}}, {"facility": "Sharp Grossmont Hospital", "city": "La Mesa", "state": "California", "zip": "91942", "country": "United States", "geoPoint": {"lat": 32.76783, "lon": -117.02308}}, {"facility": "Yale New Haven Hospital", "city": "New Haven", "state": "Connecticut", "zip": "06510", "country": "United States", "geoPoint": {"lat": 41.30815, "lon": -72.92816}}, {"facility": "VA Connecticut Healthcare System (VACHS)", "city": "West Haven", "state": "Connecticut", "zip": "06516", "country": "United States", "geoPoint": {"lat": 41.27065, "lon": -72.94705}}, {"facility": "Cardiology Physicians PA/Red Clay Research, LLC", "city": "Newark", "state": "Delaware", "zip": "19713", "country": "United States", "geoPoint": {"lat": 39.68372, "lon": -75.74966}}, {"facility": "Bethesda Health", "city": "Boynton Beach", "state": "Florida", "zip": "33435", "country": "United States", "geoPoint": {"lat": 26.52535, "lon": -80.06643}}, {"facility": "University of Florida Health Jacksonville", "city": "Jacksonville", "state": "Florida", "zip": "32209", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"facility": "University of Miami Hospital", "city": "Miami", "state": "Florida", "zip": "33136", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "Cardiology Consultants", "city": "Pensacola", "state": "Florida", "zip": "32501", "country": "United States", "geoPoint": {"lat": 30.42131, "lon": -87.21691}}, {"facility": "South Miami Heart Specialists", "city": "South Miami", "state": "Florida", "zip": "33143", "country": "United States", "geoPoint": {"lat": 25.7076, "lon": -80.29338}}, {"facility": "Tampa General Hospital", "city": "Tampa", "state": "Florida", "zip": "33606", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "University of South Florida", "city": "Tampa", "state": "Florida", "zip": "33609", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Augusta University", "city": "Augusta", "state": "Georgia", "zip": "30912", "country": "United States", "geoPoint": {"lat": 33.47097, "lon": -81.97484}}, {"facility": "Rush University Medical Center", "city": "Chicago", "state": "Illinois", "zip": "60612", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Northwestern University", "city": "Evanston", "state": "Illinois", "zip": "60208", "country": "United States", "geoPoint": {"lat": 42.04114, "lon": -87.69006}}, {"facility": "MMP ME Health Cardiology", "city": "Scarborough", "state": "Maine", "zip": "04074", "country": "United States", "geoPoint": {"lat": 43.57814, "lon": -70.32172}}, {"facility": "MedStar Shah Medical Group", "city": "Charlotte Hall", "state": "Maryland", "zip": "20622", "country": "United States", "geoPoint": {"lat": 38.48096, "lon": -76.77802}}, {"facility": "Boston Medical Center", "city": "Boston", "state": "Massachusetts", "zip": "02118", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Department of Cardiology, K-14 (Henry Ford Health System)", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Regions Hospital and Regions Heart Center Clinic", "city": "Saint Paul", "state": "Minnesota", "zip": "55101", "country": "United States", "geoPoint": {"lat": 44.94441, "lon": -93.09327}}, {"facility": "Montefiore Medical Center", "city": "Bronx", "state": "New York", "zip": "10467", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "University at Buffalo", "city": "Buffalo", "state": "New York", "zip": "14203", "country": "United States", "geoPoint": {"lat": 42.88645, "lon": -78.87837}}, {"facility": "Advanced Cardiology Group", "city": "Buffalo", "state": "New York", "zip": "14215", "country": "United States", "geoPoint": {"lat": 42.88645, "lon": -78.87837}}, {"facility": "WakeMed", "city": "Raleigh", "state": "North Carolina", "zip": "27610", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"facility": "Veterans Affairs North Texas Healthcare System", "city": "Dallas", "state": "Texas", "zip": "75216", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Houston Methodist Hospital", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Texas Institute of Cardiology, PA", "city": "McKinney", "state": "Texas", "zip": "75071", "country": "United States", "geoPoint": {"lat": 33.19762, "lon": -96.61527}}, {"facility": "Victoria Heart and Vascular Center", "city": "Victoria", "state": "Texas", "zip": "77901", "country": "United States", "geoPoint": {"lat": 28.80527, "lon": -97.0036}}, {"facility": "University of Calgary", "city": "Calgary", "state": "Alberta", "zip": "T2N 1N4", "country": "Canada", "geoPoint": {"lat": 51.05011, "lon": -114.08529}}, {"facility": "Royal Alexandra Hospital", "city": "Edmonton", "state": "Alberta", "zip": "T5H3V9", "country": "Canada", "geoPoint": {"lat": 53.55014, "lon": -113.46871}}, {"facility": "London Health Sciences Centre", "city": "London", "state": "Ontario", "zip": "N6A 5A5", "country": "Canada", "geoPoint": {"lat": 42.98339, "lon": -81.23304}}, {"facility": "St. Michael's Hospital", "city": "Toronto", "state": "Ontario", "zip": "M5B 1W8", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Montreal Heart Institute", "city": "Montreal", "state": "Quebec", "zip": "H1T 1C8", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "CIUSSS de L'Estrie - CHUS Hopital Fleurimont", "city": "Sherbrooke", "state": "Quebec", "zip": "J1H 5N4", "country": "Canada", "geoPoint": {"lat": 45.40008, "lon": -71.89908}}, {"facility": "Institut Universitaire De Cardiologie Et De Pneumologie De Quebec", "city": "Quebec", "zip": "G1V 4G5", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"facility": "Fakultni nemocnice Brno Bohunice", "city": "Brno", "zip": "625 00", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "Fakultni nemocnice u sv. Anny v Brne", "city": "Brno", "zip": "656 91", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "FN Hradec Kralove", "city": "Hradec Kralove", "zip": "500 05", "country": "Czechia", "geoPoint": {"lat": 50.20923, "lon": 15.83277}}, {"facility": "Krajska nemocnice Liberec", "city": "Liberec", "zip": "460 63", "country": "Czechia", "geoPoint": {"lat": 50.76711, "lon": 15.05619}}, {"facility": "Fakultni nemocnice Plzen", "city": "Lochot\u00edn", "zip": "304 60", "country": "Czechia", "geoPoint": {"lat": 50.1913, "lon": 13.17283}}, {"facility": "Fakultni nemocnice v Kralovske Vinohrady", "city": "Praha 10", "zip": "100 34", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Fakultni nemocnice v Motole", "city": "Praha 5", "zip": "150 06", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Masarykova nemocnice v Usti nad Labem", "city": "Usti nad Labem", "zip": "40001", "country": "Czechia", "geoPoint": {"lat": 50.6607, "lon": 14.03227}}, {"facility": "CHR Metz-Thionville - Site de Mercy", "city": "Ars Laquenexy", "zip": "57530", "country": "France", "geoPoint": {"lat": 49.09158, "lon": 6.26905}}, {"facility": "CH Antoine Beclere", "city": "Clamart", "zip": "92140", "country": "France", "geoPoint": {"lat": 48.80299, "lon": 2.26692}}, {"facility": "CHU Clermont-Ferrand, 63003 Montalembert", "city": "Clermont-Ferrand", "country": "France", "geoPoint": {"lat": 45.77966, "lon": 3.08628}}, {"facility": "CHU Henri Mondor", "city": "Cr\u00e9teil", "zip": "94010", "country": "France", "geoPoint": {"lat": 48.78333, "lon": 2.46667}}, {"facility": "CHRU de Lille", "city": "Lille", "zip": "59037", "country": "France", "geoPoint": {"lat": 50.63297, "lon": 3.05858}}, {"facility": "Hopital de Rangueil CHU Toulouse", "city": "Toulouse Cedex 9", "zip": "31059", "country": "France", "geoPoint": {"lat": 43.60426, "lon": 1.44367}}, {"facility": "Clinique Pasteur", "city": "Toulouse", "zip": "31300", "country": "France", "geoPoint": {"lat": 43.60426, "lon": 1.44367}}, {"facility": "Hopitaux de Brabois Chu Nancy", "city": "Vandoeuvre Les Nancy Cedex", "zip": "54511", "country": "France", "geoPoint": {"lat": 48.65, "lon": 6.18333}}, {"facility": "Kliniken Maria Hilf GmbH, Klinik fur Nuklearmedizin", "city": "Monchengladbach", "zip": "41063", "country": "Germany", "geoPoint": {"lat": 51.18539, "lon": 6.44172}}, {"facility": "Klinik & Poliklinik fur Nuklearmedizin, LMU, Campus Grobhader", "city": "Munich", "country": "Germany", "geoPoint": {"lat": 48.13743, "lon": 11.57549}}, {"facility": "Varosmajori Sziv es Ergyogyaszati Klinika", "city": "Budapest", "zip": "1112", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Budai Irgalmasrendi Korhaz", "city": "Budapest", "zip": "H-1023", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Gottsegen Gyorgy Orszagos Kardiologiai Intezet", "city": "Budapest", "zip": "H-1134", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Magyar Honvedseg Egeszsegugyi Kozpont Kardiol\u00f3gia Oszt\u00e1ly/Nuklearis Medicina Osztaly", "city": "Budapest", "zip": "H-1134", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Semmelweis Egyetem Nuklearis Medicina Kozpont", "city": "Budapest", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Debreceni Egyetem, Kardiologia Intezet and ScanoMed Nuclear Medicine Institute", "city": "Debrecen", "zip": "4032", "country": "Hungary", "geoPoint": {"lat": 47.53333, "lon": 21.63333}}, {"facility": "Coromed-SMO ft.", "city": "P\u00e9cs", "zip": "H-7623", "country": "Hungary", "geoPoint": {"lat": 46.08333, "lon": 18.23333}}, {"facility": "Azienda Ospedaliera Universitaria G. Martino", "city": "Messina", "zip": "98125", "country": "Italy", "geoPoint": {"lat": 38.19394, "lon": 15.55256}}, {"facility": "Area Cardiologia Critica - IRCCS Centro Cardiologico Mozino", "city": "Milano", "zip": "20138", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"facility": "Ospedale Santa Croce", "city": "Moncalieri", "zip": "10024", "country": "Italy", "geoPoint": {"lat": 44.9994, "lon": 7.68236}}, {"facility": "Azienda Ospedaliero-Universitaria Federico II Dipartimento ad Attivita Integrata di Cardiologia,Cardiochirurgia ed Emergenze Cardiovascolari", "city": "Napoli", "zip": "80131", "country": "Italy", "geoPoint": {"lat": 40.85216, "lon": 14.26811}}, {"facility": "Azienda Ospedaliero-Universitaria Maggiore della Carit\u00e0, Dipartimento Cardiologico, Cardiologia 1", "city": "Novara", "zip": "28100", "country": "Italy", "geoPoint": {"lat": 45.44694, "lon": 8.62118}}, {"facility": "Instituti Clinici Scientifici Maugeri Spa Societa Benefit", "city": "Pavia", "zip": "27100", "country": "Italy", "geoPoint": {"lat": 45.19205, "lon": 9.15917}}, {"facility": "Dipartimento di Scienze Cardiovascolari, Respiratorie Neufrologiche e Geriatriche - Universita di Roma \"La Sapienza\"", "city": "Rome", "zip": "00161", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "Ospedale Santa Maria di Ca' Foncello", "city": "Treviso", "zip": "31100", "country": "Italy", "geoPoint": {"lat": 45.66673, "lon": 12.2416}}, {"facility": "Venezia Mestre - Azienda ULSS 12 \"Veneziana\"", "city": "Venezia", "zip": "30174", "country": "Italy", "geoPoint": {"lat": 45.43713, "lon": 12.33265}}, {"facility": "Ospedale dell'Angelo, 30174, Venezia Mestre", "city": "Venice", "country": "Italy", "geoPoint": {"lat": 45.43713, "lon": 12.33265}}, {"facility": "Onze Lieve Vrouwen Gasthuis", "city": "Amsterdam", "zip": "1091 AC", "country": "Netherlands", "geoPoint": {"lat": 52.37403, "lon": 4.88969}}, {"facility": "Academic Medical Center", "city": "Amsterdam", "zip": "1105 AZ", "country": "Netherlands", "geoPoint": {"lat": 52.37403, "lon": 4.88969}}, {"facility": "Amphia Zickenhuis", "city": "Breda", "zip": "4818 CK", "country": "Netherlands", "geoPoint": {"lat": 51.58656, "lon": 4.77596}}, {"facility": "Leiden University Medical Center", "city": "Leiden", "zip": "2333 ZA", "country": "Netherlands", "geoPoint": {"lat": 52.15833, "lon": 4.49306}}, {"facility": "Maastricht University Medical Center", "city": "Maastricht", "zip": "6229 HX", "country": "Netherlands", "geoPoint": {"lat": 50.84833, "lon": 5.68889}}, {"facility": "Uniwersytecki Szpital Kliniczny w Bialymstoku", "city": "Bialystok", "zip": "15-276", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Uniwersyteckie Centrum Kliniczne", "city": "Gda\u0144sk", "zip": "80-952", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"facility": "Samodzielny Publiczny Szpital Kliniczny Nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach", "city": "Katowice", "zip": "40-635", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"facility": "Krakowski Szpital Specjalistyczny im. Jana Pawla II", "city": "Krakow", "zip": "31-202", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Wojskowy Instytut Medyczny", "city": "Warsaw", "zip": "04-141", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "Samodzielny Publiczny Centralny Szpital Kliniczny", "city": "Warsaw", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "Dolno\u015bl\u0105ski Szpital Specjalistyczny im. T. Marciniaka Centrum Medycyny Ratunkowej", "city": "Wroc\u0142aw", "zip": "54-049", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "Hospital Clinico Universitario Virgen de la Arrixaca", "city": "El Palmar (Murcia)", "zip": "30120", "country": "Spain"}, {"facility": "Hospital Universitario Virgen de las Nieves", "city": "Granada", "zip": "18014", "country": "Spain", "geoPoint": {"lat": 37.18817, "lon": -3.60667}}, {"facility": "Hospital Universitario de Leon", "city": "Le\u00f3n", "zip": "24071", "country": "Spain", "geoPoint": {"lat": 42.60003, "lon": -5.57032}}, {"facility": "Hospital Universitario Ramon y Cajal", "city": "Madrid", "zip": "28034", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Hospital Clinico Universitario San Carlos", "city": "Madrid", "zip": "28040", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Hospital Universitario Virgen de la Victoria", "city": "Malaga", "zip": "29010", "country": "Spain", "geoPoint": {"lat": 36.72016, "lon": -4.42034}}, {"facility": "Hospital Universitario Son Espases", "city": "Palma de Mallorca (Illes Balears)", "zip": "07120", "country": "Spain", "geoPoint": {"lat": 39.56939, "lon": 2.65024}}, {"facility": "Hospital Cl\u00ednico de Salamanca", "city": "Salamanca", "zip": "37002", "country": "Spain", "geoPoint": {"lat": 40.96882, "lon": -5.66388}}, {"facility": "Hospital Universitario San Juan de Alicante", "city": "San Juan Alicante", "zip": "03550", "country": "Spain"}, {"facility": "Complejo Hospitalario Universitario de Santiago", "city": "Santiago De Compostela (A Coru\u00f1a)", "zip": "15706", "country": "Spain"}, {"facility": "Hospital General Universitario de Valencia", "city": "Valencia", "zip": "46014", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Out of 343 participants, 321 participants with 25% \\<=left ventricular ejection fraction (LVEF) \\<=35% were randomized in a 1:1 ratio to the AdreView\u2122 group or Standard of Care (SoC) group stratified by enrolling center via an interactive web response system and 22 participants were not randomized but included in safety analysis set.", "recruitmentDetails": "The Study was conducted at 70 centers in United States of America, Canada and Europe between 30 December 2015 and 04 May 2018. A total of 395 participants were enrolled in study, of which 52 were screen failures mainly due to exclusion criteria met.", "groups": [{"id": "FG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 millicurie (mCi) (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 Heart-to-Mediastinal ratio (H/M) \\<1.6 underwent Implantable Cardioverter Defibrillator (ICD) device implantation and H/M \\>= 1.6 continued to receive Guideline-Directed Optimal Medical Therapy (GDMT) according to clinical standard practice."}, {"id": "FG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted Heart Failure (HF) guidelines."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "164"}, {"groupId": "FG001", "numSubjects": "157"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "164"}, {"groupId": "FG001", "numSubjects": "157"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "3"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "Study termination by Sponsor", "reasons": [{"groupId": "FG000", "numSubjects": "150"}, {"groupId": "FG001", "numSubjects": "142"}]}, {"type": "Other than specified above", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "6"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Baseline population included randomized participants.", "groups": [{"id": "BG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 Heart-to-Mediastinal ratio (H/M) \\<1.6 underwent Implantable Cardioverter Defibrillator (ICD) device implantation and H/M \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "BG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "164"}, {"groupId": "BG001", "value": "157"}, {"groupId": "BG002", "value": "321"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "64.1", "spread": "9.40"}, {"groupId": "BG001", "value": "62.1", "spread": "10.05"}, {"groupId": "BG002", "value": "63.1", "spread": "9.76"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "35"}, {"groupId": "BG001", "value": "22"}, {"groupId": "BG002", "value": "57"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "129"}, {"groupId": "BG001", "value": "135"}, {"groupId": "BG002", "value": "264"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "26"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "142"}, {"groupId": "BG001", "value": "140"}, {"groupId": "BG002", "value": "282"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "13"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "3"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "19"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "149"}, {"groupId": "BG001", "value": "137"}, {"groupId": "BG002", "value": "286"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "13"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "All-cause Mortality", "description": "All-cause mortality included all reported deaths of participants during the study due to any cause. Percentage of participants who died due to any cause were reported.", "populationDescription": "Analysis was performed on full analysis set (FAS) that was defined as participants included in the safety analysis set who were randomised to the AdreView\u2122 group or the SoC group.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.0"}, {"groupId": "OG001", "value": "3.2"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Analysis was performed using the Cox proportional hazards model stratified by country, with method of treatment guidance (SoC vs AdreView\u2122 group) as the only covariate.", "nonInferiorityType": "NON_INFERIORITY", "nonInferiorityComment": "Non-inferiority of AdreView\u2122 group over SoC group was demonstrated if upper bound of the 95% confidence interval (CI) for the hazard ratio (HR) (AdreView\u2122 group / SoC) was equal to 1.20.", "pValue": "0.8459", "pValueComment": "Threshold for significance at 0.025 level.", "statisticalMethod": "Log Rank", "paramType": "Hazard Ratio (HR)", "paramValue": "1.047", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.295", "ciUpperLimit": "3.719", "estimateComment": "AdreView\u2122 vs. Standard of Care"}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Events of Complications of Device: H/M >=1.6 in Full Analysis Set", "description": "Composite of the percentage of participants with events of hospitalization or death related to major complications of device implantation (i.e., need for thoracotomy, pericardiocentesis, or vascular surgery), complications of long-term device therapy (i.e., infection not leading to hospitalization, lead and/or generator removal/replacement, inappropriate shocks, explanation), and combined as 'complications of device' for participants with H/M \\>=1.6. Participants who were alive at time of database lock (DBL) were censored at the last known-alive date.", "populationDescription": "Analysis was performed on FAS population. Here, overall number of participants analyzed = participants with H/M \\>=1.6.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "20"}]}], "classes": [{"title": "Hospitalization/death", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.8"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Complications of long-term device therapy", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.8"}, {"groupId": "OG001", "value": "15.0"}]}]}, {"title": "Complications of device", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.8"}, {"groupId": "OG001", "value": "15.0"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Cardiac Death", "description": "Cardiac death composed of sudden cardiac death, death due to cardiac arrhythmia, death due to heart failure, and death due to other cardiovascular causes.", "populationDescription": "Analysis was performed on FAS population.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.2"}, {"groupId": "OG001", "value": "0.6"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Hospitalization for Cardiovascular Cause", "description": "Percentage of participants who were hospitalized for cardiovascular cause were reported.", "populationDescription": "Analysis was performed on FAS population.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7.3"}, {"groupId": "OG001", "value": "7.6"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With All-Cause Hospitalization", "description": "Percentage of participants with all-cause hospitalization were reported.", "populationDescription": "Analysis was performed on FAS population.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "17.1"}, {"groupId": "OG001", "value": "22.3"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Events (Composite of the Occurrence of Resuscitated Life-Threatening Ventricular Tachycardia, Unstable Ventricular Tachyarrhythmias, Sudden Cardiac Death [SCD] and Resuscitated Cardiac Arrest)", "description": "Percentage of participants with composite events i.e occurrence of resuscitated life-threatening ventricular tachycardia, unstable ventricular tachy-arrhythmias, SCD and resuscitated cardiac arrest were reported. Participants who were alive at time of database lock (DBL) were censored at the last known-alive date.", "populationDescription": "Analysis was performed on FAS population.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.2"}, {"groupId": "OG001", "value": "2.5"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Syncope", "description": "Percentage of participants with Syncope were reported. Participants who were alive at time of DBL were censored at the last known-alive date by date of DBL.", "populationDescription": "Analysis was performed on FAS population.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.4"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Implantable Cardioverter Defibrillator (ICD) Implantation", "description": "Percentage of participants with ICD implantation were reported.", "populationDescription": "Analysis was performed on FAS population.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "73.2"}, {"groupId": "OG001", "value": "81.5"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Events of Complications of Device", "description": "Composite of the percentage of participants with events of hospitalization or death related to major complications of device implantation (i.e., need for thoracotomy, pericardiocentesis, or vascular surgery), complications of long-term device therapy (i.e., infection not leading to hospitalization, lead and/or generator removal/replacement, inappropriate shocks, explanation), and combined as 'complications of device'.", "populationDescription": "Analysis was performed on FAS population.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of participants", "timeFrame": "From randomization until the end of the follow-up period (median 304 days)", "groups": [{"id": "OG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice."}, {"id": "OG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "157"}]}], "classes": [{"title": "Hospitalization/death", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.9"}, {"groupId": "OG001", "value": "3.8"}]}]}, {"title": "Complications of long-term device therapy", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.3"}, {"groupId": "OG001", "value": "6.4"}]}]}, {"title": "Complications of device", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.5"}, {"groupId": "OG001", "value": "6.4"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "All Adverse Events (AEs) were collected from randomization until the end of the follow-up period (median 304 days) regardless of seriousness or relationship to investigational product.", "description": "Reported AEs and deaths are study-emergent AEs that is AEs and deaths that developed/worsened during any time after randomization until end of the follow-up period (median 304 days). Analysis was performed on safety population which included all participants who signed the informed consent form and met all the inclusion criteria and none of the exclusion criteria.", "eventGroups": [{"id": "EG000", "title": "AdreView\u2122", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection). Participants with AdreView\u2122 H/M ratio \\<1.6 underwent ICD device implantation and H/M ratio \\>= 1.6 continued to receive GDMT according to clinical standard practice.", "deathsNumAffected": 6, "deathsNumAtRisk": 164, "seriousNumAffected": 65, "seriousNumAtRisk": 164, "otherNumAffected": 0, "otherNumAtRisk": 164}, {"id": "EG001", "title": "Standard of Care", "description": "Participants received 1 intravenous injection of 10 mCi (370 MBq) of AdreView\u2122 (Iobenguane I-123 Injection) and underwent ICD implantation and were followed up in accordance with internationally accepted HF guidelines.", "deathsNumAffected": 5, "deathsNumAtRisk": 157, "seriousNumAffected": 62, "seriousNumAtRisk": 157, "otherNumAffected": 0, "otherNumAtRisk": 157}, {"id": "EG002", "title": "Total Participants", "description": "All participants who were randomized in AdreView\u2122 and Standard of Care group in addition with non-randomized participants who signed informed consent form.", "deathsNumAffected": 11, "deathsNumAtRisk": 343, "seriousNumAffected": 127, "seriousNumAtRisk": 343, "otherNumAffected": 0, "otherNumAtRisk": 343}], "seriousEvents": [{"term": "Iron deficiency anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Leukocytosis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Normochromic normocytic anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 343}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 343}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 343}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 343}]}, {"term": "Cardiac disorder", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 26, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 48, "numAtRisk": 343}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 13, "numAtRisk": 343}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 343}]}, {"term": "Cardiac perforation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Cardiac ventricular thrombosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Cardio-respiratory arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Ventricular arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Ventricular extrasystoles", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 343}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Hyperthyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Hypothyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Chronic gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Dental caries", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Diverticulum", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Dyspepsia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Dysphagia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Enteritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Gastroduodenal ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Gastrointestinal ulcer haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Gastrooesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Haemorrhoids", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Incarcerated inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Pancreatitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Rectal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Chest discomfort", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Complication associated with device", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Malaise", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Medical device site irritation", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Polyp", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 343}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Device related infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Endocarditis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Gangrene", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Helicobacter infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Implant site infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Incision site infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 343}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Otitis media", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 343}]}, {"term": "Post procedural cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Septic shock", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Streptococcal bacteraemia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Subcutaneous abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Humerus fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Lower limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Overdose", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Sternal fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Blood cholesterol increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Blood creatinine increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Blood uric acid increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "C-reactive protein increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Weight decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Cachexia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Decreased appetite", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Dyslipidaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Gout", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Hyperglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Hyperuricaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Hyponatraemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Lactic acidosis", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Type 2 diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Vitamin D deficiency", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Dupuytren's contracture", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Rhabdomyolysis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Colon cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Gastrointestinal stro", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Lung neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Neoplasm prostate", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Dementia Alzheimer's type", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Epilepsy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Hemiplegia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Presyncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Seizure", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 343}]}, {"term": "Transient ischaemic attack", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Device inappropriate shock delivery", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 343}]}, {"term": "Device use issue", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Lead dislodgement", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 343}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Confusional state", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 343}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Urinary bladder haemorrhage", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Benign prostatic hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Prostatitis", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Acute pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Bronchospasm", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Dyspnoea paroxysmal nocturnal", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 343}]}, {"term": "Hypoxia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Pulmonary mass", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 343}]}, {"term": "Sinus congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Sleep apnoea syndrome", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Tachypnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Implantable defibrillator insertion", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 343}]}, {"term": "Aortic aneurysm", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Aortic dissection", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Circulatory collapse", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 343}]}, {"term": "Intermittent claudication", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Lymphoedema", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Orthostatic hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Peripheral artery stenosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Peripheral ischaemia", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}, {"term": "Phlebitis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 164}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 157}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 343}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "The study was early terminated by sponsor after enrollment of 395 participants due to very slow recruitment rates. Sample size was 395 participants instead of planned 2354 participants."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The only disclosure restriction on the PI and/or institution is that the Sponsor can review results communications prior to public release and can restrict communications regarding trial results for a period that is more than 30 days (publications/abstracts) but not to exceed 90 days (patent related issues) from the time submitted to the Sponsor to review. The PI may be asked to remove any Sponsor confidential information and/or delay publication to protect any proprietary information."}, "pointOfContact": {"title": "Francois Tranquart, M.D., Ph.D.", "organization": "GE Healthcare", "email": "francois.tranquart@ge.com", "phone": "0-44-1494-543037"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2017-05-11", "uploadDate": "2019-04-26T04:07", "filename": "Prot_000.pdf", "size": 1760028}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2018-06-20", "uploadDate": "2019-04-26T04:08", "filename": "SAP_001.pdf", "size": 1375981}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000019797", "term": "3-Iodobenzylguanidine"}, {"id": "C000010389", "term": "Lugol's solution"}], "ancestors": [{"id": "D000000970", "term": "Antineoplastic Agents"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000019275", "term": "Radiopharmaceuticals"}, {"id": "D000006490", "term": "Hemostatics"}, {"id": "D000003029", "term": "Coagulants"}], "browseLeaves": [{"id": "M21860", "name": "Pharmaceutical Solutions", "relevance": "LOW"}, {"id": "M10488", "name": "Iodine", "relevance": "LOW"}, {"id": "M193072", "name": "Lugol's solution", "asFound": "ACD", "relevance": "HIGH"}, {"id": "M21692", "name": "3-Iodobenzylguanidine", "asFound": "Rehydration", "relevance": "HIGH"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}, {"id": "M21258", "name": "Radiopharmaceuticals", "relevance": "LOW"}, {"id": "M9576", "name": "Hemostatics", "relevance": "LOW"}, {"id": "M6259", "name": "Coagulants", "relevance": "LOW"}], "browseBranches": [{"abbrev": "PhSol", "name": "Pharmaceutical Solutions"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Micro", "name": "Micronutrients"}, {"abbrev": "Infe", "name": "Anti-Infective Agents"}, {"abbrev": "Coag", "name": "Coagulants"}, {"abbrev": "ANeo", "name": "Antineoplastic Agents"}]}}, "hasResults": true}